# BP-C1 in Metastatic Breast Cancer Patients

> **NCT01861509** · PHASE1 · COMPLETED · sponsor: **Meabco A/S** · enrollment: 10 (actual)

## Conditions studied

- Metastatic Breast Cancer
- Stage IV Breast Cancer

## Interventions

- **DRUG:** BP-C1

## Key facts

- **NCT ID:** NCT01861509
- **Lead sponsor:** Meabco A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-19
- **Primary completion:** 2016-01-20
- **Final completion:** 2016-01-20
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01861509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01861509, "BP-C1 in Metastatic Breast Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01861509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*